drug interaction, ambulatory cancer patients, OTC drugs.
Conditions
Interventions
The patients are asked to complete a short questionnaire followed by an interview. The questionnaire contains questions about the demographic characteristics (available online as appendix). A list of
Sponsors
VU university medical center, Zaans Medical Center
Eligibility
Inclusion criteria
Inclusion criteria: All patients with solid and hematologic malignancy currently using systemic anti-cancer drugs are asked to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Unable to fill out questionnaires; 2. The use of trial medication; 3. A lack of command of the Dutch language; 4. Younger than 18 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the present study is to gain more insight into the prevalence of interactions and duplicate prescriptions among cancer patients being treated in the outpatient day care departments for oncology and hemato-oncology. This will be the first study into the prevalence of drug interactions with OTC-drugs in cancer patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible risk factors for the occurrence of these drug-related problems will also be studied. | — |
Contacts
Public ContactJ.G. Hugtenburg
Clinical Pharmacology and Pharmacy VU University Medical Center PO Box 7057
Outcome results
None listed